| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
On CNBC's “Mad Money Lightning Round,” Jim Cramer said United States Antimony Corporation (NYSE:UAMY) is a “spec that actually makes money.”
As per the recent news, United States Antimony, on Sept. 23, announced a collaboration with the U.S. Defense Logistics Agency (DLA). U.S. Antimony has been awarded an Indefinite Delivery Indefinite Quantity (IDIQ) sole-source contract by the DLA Strategic Materials for up to $245 million. The contract is for the purchase of antimony metal ingots to aid in the replenishment of the National Defense Stockpile.
Amphenol Corporation (NYSE:APH) is a good company, Cramer said. “It's just a rocket ship, I know.”
Lending support to his choice, Goldman Sachs analyst Mark Delaney maintained Amphenol with a Buy rating on Monday and raised the price target from $124 to $139.
Citigroup analyst Asiya Merchant, on Sept. 24, also maintained the stock with a Buy and boosted the price target from $125 to $145.
Price Action:
Read Next:
Image: Shutterstock
